Cited 0 times in 
Cited 0 times in 
Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Abu-Farha, Mohamed | - |
| dc.contributor.author | Lee, Yong Ho | - |
| dc.contributor.author | Abubaker, Jehad | - |
| dc.date.accessioned | 2023-03-03T02:35:08Z | - |
| dc.date.available | 2023-03-03T02:35:08Z | - |
| dc.date.created | 2023-01-19 | - |
| dc.date.issued | 2022-09 | - |
| dc.identifier.issn | 1664-2392 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/192856 | - |
| dc.description.abstract | No abstract available | - |
| dc.description.statementOfResponsibility | open | - |
| dc.language | English | - |
| dc.publisher | Frontiers Research | - |
| dc.relation.isPartOf | Frontiers in Endocrinology | - |
| dc.relation.isPartOf | FRONTIERS IN ENDOCRINOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Abu-Farha, Mohamed | - |
| dc.contributor.googleauthor | Lee, Yong Ho | - |
| dc.contributor.googleauthor | Abubaker, Jehad | - |
| dc.identifier.doi | 10.3389/fendo.2022.1010485 | - |
| dc.relation.journalcode | J03412 | - |
| dc.identifier.eissn | 1664-2392 | - |
| dc.identifier.pmid | 36120468 | - |
| dc.subject.keyword | NAFLD | - |
| dc.subject.keyword | GLP1 agonist | - |
| dc.subject.keyword | SGLT2 (sodium-glucose cotransporter 2) inhibitor | - |
| dc.subject.keyword | thiazolidinediones | - |
| dc.subject.keyword | liver fat | - |
| dc.contributor.alternativeName | Lee, Yong Ho | - |
| dc.contributor.affiliatedAuthor | Lee, Yong Ho | - |
| dc.identifier.scopusid | 2-s2.0-85138277614 | - |
| dc.identifier.wosid | 000874956000001 | - |
| dc.citation.volume | 13 | - |
| dc.identifier.bibliographicCitation | Frontiers in Endocrinology, Vol.13, 2022-09 | - |
| dc.identifier.rimsid | 76984 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | NAFLD | - |
| dc.subject.keywordAuthor | GLP1 agonist | - |
| dc.subject.keywordAuthor | SGLT2 (sodium-glucose cotransporter 2) inhibitor | - |
| dc.subject.keywordAuthor | thiazolidinediones | - |
| dc.subject.keywordAuthor | liver fat | - |
| dc.type.docType | Editorial Material | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
| dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
| dc.identifier.articleno | 1010485 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.